Primary ciliary dyskinesia

QJM: An International Journal of Medicine

Volumn 107, Issue 9, 2014, Pages 691-699

  Lobo, L J ^a   Zariwala, M A ^a   Noone, P G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; NITRIC OXIDE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CILIARY DYSKINESIA; DIAGNOSTIC TEST; GENETIC ANALYSIS; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; DISEASE MANAGEMENT; EARLY DIAGNOSIS; EUKARYOTIC FLAGELLUM; FORECASTING; GENETIC ASSOCIATION; GENETIC SCREENING; GENETICS; INTERNATIONAL COOPERATION; KARTAGENER SYNDROME; MICROBIOLOGY; MUCOCILIARY CLEARANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SECONDARY CARE CENTER; TRENDS; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; CILIA; DISEASE MANAGEMENT; EARLY DIAGNOSIS; FORECASTING; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERNATIONAL COOPERATION; KARTAGENER SYNDROME; MUCOCILIARY CLEARANCE; RESPIRATORY SYSTEM; SECONDARY CARE CENTERS;

EID: 84906838581     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu063     Document Type: Article

References (25)

1. Online Mendelian Inheritance in Man (OMIM), http://www.omim.org/.
2. Knowles MR, Daniels LA, Davis SD, Zariwala MA, Leigh MW. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Resp Crit Care 2013; 188:913-22.
3. Onoufriadis A, PaffT, Antony D, Shoemark A, Micha D, Kuyt B, et al. Splice-site mutations in the axonemal outer dynein arm docking complex gene CCDC114 cause primary ciliary dyskinesia. Am J Hum Genet 2013; 92:88-98.
4. Leigh MW, O'Callaghan C, Knowles MR. The challenges of diagnosing primary ciliary dyskinesia. Proc Am Thorac Soc 2011; 8:434-7.
5. Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Resp Crit Care 2004; 169:459-67.
6. Sagel SD, Davis SD, Campisi P, Dell SD. Update of respiratory tract disease in children with primary ciliary dyskinesia. Proc Am Thorac Soc 2011; 8:438-43.
7. Kennedy MP, Noone PG, Leigh MW, Zariwala MA, Minnix SL, Knowles MR, et al. High-resolution CT of patients with primary ciliary dyskinesia. AJR Am J Roentgenol 2007; 188:1232-8.
8. Leigh MW, Hazucha MJ, Chawla KK, Baker BR, Shapiro AJ, Brown DE, et al. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc 2013; 10:574-81.
9. Santamaria F, de Santi MM, Grillo G, Sarnelli P, Caterino M, Greco L. Ciliary motility at light microscopy: a screening technique for ciliary defects. Acta Paediatr 1999; 88:853-7.
10. Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J 2009; 34:1264-76.
11. Panizzi JR, Becker-Heck A, Castleman VH, Al-Mutairi DA, Liu Y, Loges NT, et al. CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms. Nat Genet 2012; 44:714-9.
12. Genetic Disorders of Mucociliary Clearance Consortium(GDMCC), http://rarediseasesnetwork.epi.usf. edu/gdmcc/index.htm.
13. Fliegauf M, Olbrich H, Horvath J, Wildhaber JH, Zariwala MA, Kennedy M, et al. Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia. Am J Resp Crit Care 2005; 171:1343-9.
14. Merveille AC, Davis EE, Becker-Heck A, Legendre M, Amirav I, Bataille G, et al. CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs. Nat Genet 2011; 43:72-8.
15. Antony D, Becker-Heck A, Zariwala MA, Schmidts M, Onoufriadis A, Forouhan M, et al. Mutations in CCDC39 and CCDC40 are the major cause of primary ciliary dyskinesia with axonemal disorganization and absent inner dynein arms. Hum Mutat 2013; 34:462-72.
16. Gene Reviews, http://www.ncbi.nlm.nih.gov.
17. Kellett F, Robert NM. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Resp Med 2011; 105:1831-5.
18. O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 1998; 113:1329-34.
19. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Jr, Willey-Courand DB, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Resp Crit Care 2007; 176:957-69.
20. Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane DB Syst Rev 2007; 18:CD001392.
21. White L, Mirrani G, Grover M, Rollason J, Malin A, Suntharalingam J. Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis. Resp Med 2012; 106:356-60.
22. Murray MP, Govan JR, Doherty CJ, Simpson AJ, Wilkinson TS, Chalmers JD, et al. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Resp Crit Care 2011; 183:491-9.
23. Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, et al. Azithromycin for prevention of exacerbations in noncystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 380:660-7.
24. Campbell R. Managing upper respiratory tract complications of primary ciliary dyskinesia in children. Curr Opin Allergy CL 2012; 12:32-8.
25. Ellerman A, Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J 1997; 10:2376-9.